Author: WebTeam

A study published this month by the Journal of Alzheimher’s Disease has found that both THC (tetrahydrocannabinol) and CBD (cannabidiol) may provide a viable treatment option for Alzheimer’s Disease, and combining the cannabis compounds is even more effective. “Several recent findings suggest that targeting the endogenous cannabinoid system can be considered as a potential therapeutic approach to treat Alzheimer’s disease (AD)”, begins the study’s abstract. “The present study supports this hypothesis demonstrating that delta-9-tetrahydrocannabinol (THC) or cannabidiol (CBD) botanical extracts, as well as the combination of both natural cannabinoids, which are the components of an already approved cannabis-based medicine, preserved…

Read More

The Argentina federal government, with support from President Cristina Kirchner, has begun work on two proposals aimed at legalizing the personal possession of all drugs, and to legalize the private cultivation of cannabis. The plan is to have the proposals finished, and in front of Congress, by the year’s end, according to Argentine newspaper La Nacion. The proposals are aimed at preventing the disastrous consequences placed upon individuals who are simply possessing a small amount of illegal drugs or cultivating a few cannabis plants, and to put a damper on the black market, which often times enriches criminal syndicates. Under…

Read More

August 2, 2014, A new study published last week by the journal Biochemical Pharmacology, and published online by the National Institute of Health, has found that cannabinoids can increase a cancer cell’s susceptibility to cytolysis, which occurs when a cell bursts due to an imbalance. “Cannabinoids have been shown to promote the expression of the intercellular adhesion molecule 1 (ICAM-1) on lung cancer cells as part of their anti-invasive and antimetastatic action”, says Burkhard Hinz, the study’s lead author. “Using lung cancer cell lines (A549, H460) and metastatic cells derived from a lung cancer patient, the present study addressed the…

Read More

A new study being published in this month’s issue of the journal Experimental Neurology, and published online this week by the U.S. National Institute of Health, has found that stimulation of the body’s cannabinoid receptors – such as through the consumption of cannabis – attenuates early brain injury. For the study, researchers evaluated whether a cannabinoid receptor type 2 (CB2R) agonist (something which cannabis is) attenuates early brain injury (EBI) after SAH [subarachnoid hemorrhage], and “whether CB2R stimulation reduces pro-apoptotic caspase-3 via up-regulation of cAMP response element-binding protein (CREB)-Bcl-2 signaling pathway.” “Male Sprague Dawley rats” were subjected to SAH by…

Read More

Research from the University of Manchester sheds new light on the impact of marijuana use on schizophrenia. The study, published July 9 in the journal Schizophrenia Bulletin, followed 110 individuals with a schizophrenia diagnosis over an 18 month period to determine whether cannabis use had an effect on their illness. “There was no evidence of a specific association between cannabis use and positive symptoms, or negative symptoms, relapse or hospital admissions,” wrote Christine Barrowclough, PhD, a professor of clinical psychology at the University of Manchester and the study’s lead author. Symptoms in schizophrenia are split into two categories. Positive symptoms…

Read More

A new study out of the Netherlands has determined THC use to be safe for older adults, specifically those over 65. Researchers from the Department of Geriatric Medicine and Radboud Alzheimer Centre, the Department of Pharmacy, the Department for Health Evidence and the Department of Pharmacology and Toxicology out of Radboud University Medical Center reviewed the effects of pure THC when administered to adults over the age of 65. The results, while unsurprising to some, offer new evidence that THC can provide treatment for a myriad of ailments for people of all ages. The abstract of the study begins as…

Read More

A German court in Cologne has ruled that those suffering from chronic pain may grow their own cannabis for medical purposes in certain situations. The case came as five people suffering from chronic pain brought a complaint to the court claiming that the nation’s Federal Institute for Drugs and Medical Devices refused them permission to grow cannabis at home, despite them having limited access to the medicine and it not being covered by their insurance. The court ruled that three of the plaintiffs met the requirements to grow cannabis because it was “sufficiently certain” that they wouldn’t be able to…

Read More

Low doses of THC (tetrahydrocannabinol) can protect the brain from neuroinflammation-induced cognitive damage and “might be used as an effective drug for the treatment of neuroinflammatory conditions, including neurodegenerative diseases”, according to a new study published in the Journal of Neuroscience Research. “In our previous studies, we found that a single ultralow dose of tetrahydrocannabinol (THC; 0.002 mg/kg, three to four orders of magnitude lower than the conventional doses) protects the brain from different insults that cause cognitive deficits”, says the study’s researchers. “Because various insults may trigger a neuroinflammatory response that leads to secondary damage to the brain, the…

Read More

A study published in this month’s issue of the Journal of Alzheimer’s Disease, and published online ahead of print by the U.S. National Institute of Health, has found strong evidence to suggest that THC (tetrahydrocannabinol) may provide a treatment option for Alzheimer’s disease. “The purpose of this study was to investigate the potential therapeutic qualities of Δ9-tetrahydrocannabinol (THC) with respect to slowing or halting the hallmark characteristics of Alzheimer’s disease”, claims the study’s researchers. After incubated “N2a-variant amyloid-β protein precursor (AβPP) cells” with THC, researchers found that; “These sets of data strongly suggest that THC could be a potential therapeutiase…

Read More

On July 9th, 2014, Marc Emery, a Canadian politician, cannabis activist, publisher and distributor of cannabis seeds, was released from the federal correctional institution in Yazoo City, in the U.S. state of Mississippi. Emery was sentenced to five years of imprisonment in the U.S. for the online selling of cannabis seeds to American citizens. Before the extradition to the U.S., Marc was known as the publisher of Cannabis Culture Magazine and as the founder of Pot TV. He is also one of the initiators of the Freedom Party of Ontario, the Marijuana Party of Canada and the BC Marijuana Party.…

Read More